J Sex Med:体育活动对女性性功能障碍有何影响?

2021-06-23 AlexYang MedSci原创

目前仍旧缺乏关于体育活动(PA)和女性性功能障碍(FSD)之间关系的研究。近期,有研究人员调查了FSD妇女的PA与临床、心理和性相关的因素。

目前仍旧缺乏关于体育活动(PA)和女性性功能障碍(FSD)之间关系的研究。近期,有研究人员调查了FSD妇女的PA与临床、心理和性相关的因素。 研究人员对一个非选择系列的322名绝经前和绝经后的参与者进行了回顾性研究,他她们均进行了FSD咨询。并用一个特定的问卷调查了定期参与PA及其频率(<1小时/周:久坐,1-3小时/周:活跃,4-6小时/周:非常活跃,>6小时/周:非常活跃)。 研究人员根据结构化的临床访谈来诊断FSD,包括HSDD(性欲减退症)和FGAD(女性生殖器唤起障碍)。参与者接受了体检和阴蒂多普勒超声检查,并完成了女性性功能指数、女性性困扰量表-修订版、身体不适测试和Middlesex医院问卷。 在多变量分析中,与久坐不动的妇女相比,从事公共活动的妇女(67.4%,n=217)在几个女性性功能指数领域(包括欲望、唤醒和润滑)的得分明显较高,并且性困扰和阴蒂动脉阻力较低。研究人员观察到PA和HSDD之间有明显的负相关关系。中介分析表明,PA和HSDD之间的负相关关系部分由身体形象问题(身体不安测试全球严重程度指数)、心理病理症状(Middlesex医院问卷总分)和

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1665584, encodeId=ec1316655842d, content=<a href='/topic/show?id=66134464223' target=_blank style='color:#2F92EE;'>#女性性功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44642, encryptionId=66134464223, topicName=女性性功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e825973246, createdName=12498ef1m39(暂无昵称), createdTime=Wed Jan 19 00:02:05 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977135, encodeId=fcfd9e7135ab, content=Mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac645513469, createdName=ms6000000413596970, createdTime=Sat Jun 26 21:17:47 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421375, encodeId=32dd14213e547, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Fri Jun 25 13:02:05 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611105, encodeId=6b7b1611105a4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jun 25 13:02:05 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976459, encodeId=a83c9e645937, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67634708538, createdName=1356548325, createdTime=Thu Jun 24 09:35:13 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976431, encodeId=66529e643116, content=消耗1积分!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Thu Jun 24 08:12:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976414, encodeId=7e3e9e6414e1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Thu Jun 24 06:51:30 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976405, encodeId=ff069e64055b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faae5295647, createdName=148728e5m16暂无昵称, createdTime=Thu Jun 24 06:13:25 CST 2021, time=2021-06-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1665584, encodeId=ec1316655842d, content=<a href='/topic/show?id=66134464223' target=_blank style='color:#2F92EE;'>#女性性功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44642, encryptionId=66134464223, topicName=女性性功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e825973246, createdName=12498ef1m39(暂无昵称), createdTime=Wed Jan 19 00:02:05 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977135, encodeId=fcfd9e7135ab, content=Mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac645513469, createdName=ms6000000413596970, createdTime=Sat Jun 26 21:17:47 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421375, encodeId=32dd14213e547, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Fri Jun 25 13:02:05 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611105, encodeId=6b7b1611105a4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jun 25 13:02:05 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976459, encodeId=a83c9e645937, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67634708538, createdName=1356548325, createdTime=Thu Jun 24 09:35:13 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976431, encodeId=66529e643116, content=消耗1积分!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Thu Jun 24 08:12:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976414, encodeId=7e3e9e6414e1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Thu Jun 24 06:51:30 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976405, encodeId=ff069e64055b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faae5295647, createdName=148728e5m16暂无昵称, createdTime=Thu Jun 24 06:13:25 CST 2021, time=2021-06-24, status=1, ipAttribution=)]
    2021-06-26 ms6000000413596970

    Mark

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1665584, encodeId=ec1316655842d, content=<a href='/topic/show?id=66134464223' target=_blank style='color:#2F92EE;'>#女性性功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44642, encryptionId=66134464223, topicName=女性性功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e825973246, createdName=12498ef1m39(暂无昵称), createdTime=Wed Jan 19 00:02:05 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977135, encodeId=fcfd9e7135ab, content=Mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac645513469, createdName=ms6000000413596970, createdTime=Sat Jun 26 21:17:47 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421375, encodeId=32dd14213e547, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Fri Jun 25 13:02:05 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611105, encodeId=6b7b1611105a4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jun 25 13:02:05 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976459, encodeId=a83c9e645937, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67634708538, createdName=1356548325, createdTime=Thu Jun 24 09:35:13 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976431, encodeId=66529e643116, content=消耗1积分!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Thu Jun 24 08:12:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976414, encodeId=7e3e9e6414e1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Thu Jun 24 06:51:30 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976405, encodeId=ff069e64055b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faae5295647, createdName=148728e5m16暂无昵称, createdTime=Thu Jun 24 06:13:25 CST 2021, time=2021-06-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1665584, encodeId=ec1316655842d, content=<a href='/topic/show?id=66134464223' target=_blank style='color:#2F92EE;'>#女性性功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44642, encryptionId=66134464223, topicName=女性性功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e825973246, createdName=12498ef1m39(暂无昵称), createdTime=Wed Jan 19 00:02:05 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977135, encodeId=fcfd9e7135ab, content=Mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac645513469, createdName=ms6000000413596970, createdTime=Sat Jun 26 21:17:47 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421375, encodeId=32dd14213e547, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Fri Jun 25 13:02:05 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611105, encodeId=6b7b1611105a4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jun 25 13:02:05 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976459, encodeId=a83c9e645937, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67634708538, createdName=1356548325, createdTime=Thu Jun 24 09:35:13 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976431, encodeId=66529e643116, content=消耗1积分!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Thu Jun 24 08:12:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976414, encodeId=7e3e9e6414e1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Thu Jun 24 06:51:30 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976405, encodeId=ff069e64055b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faae5295647, createdName=148728e5m16暂无昵称, createdTime=Thu Jun 24 06:13:25 CST 2021, time=2021-06-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1665584, encodeId=ec1316655842d, content=<a href='/topic/show?id=66134464223' target=_blank style='color:#2F92EE;'>#女性性功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44642, encryptionId=66134464223, topicName=女性性功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e825973246, createdName=12498ef1m39(暂无昵称), createdTime=Wed Jan 19 00:02:05 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977135, encodeId=fcfd9e7135ab, content=Mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac645513469, createdName=ms6000000413596970, createdTime=Sat Jun 26 21:17:47 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421375, encodeId=32dd14213e547, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Fri Jun 25 13:02:05 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611105, encodeId=6b7b1611105a4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jun 25 13:02:05 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976459, encodeId=a83c9e645937, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67634708538, createdName=1356548325, createdTime=Thu Jun 24 09:35:13 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976431, encodeId=66529e643116, content=消耗1积分!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Thu Jun 24 08:12:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976414, encodeId=7e3e9e6414e1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Thu Jun 24 06:51:30 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976405, encodeId=ff069e64055b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faae5295647, createdName=148728e5m16暂无昵称, createdTime=Thu Jun 24 06:13:25 CST 2021, time=2021-06-24, status=1, ipAttribution=)]
    2021-06-24 1356548325

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1665584, encodeId=ec1316655842d, content=<a href='/topic/show?id=66134464223' target=_blank style='color:#2F92EE;'>#女性性功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44642, encryptionId=66134464223, topicName=女性性功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e825973246, createdName=12498ef1m39(暂无昵称), createdTime=Wed Jan 19 00:02:05 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977135, encodeId=fcfd9e7135ab, content=Mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac645513469, createdName=ms6000000413596970, createdTime=Sat Jun 26 21:17:47 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421375, encodeId=32dd14213e547, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Fri Jun 25 13:02:05 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611105, encodeId=6b7b1611105a4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jun 25 13:02:05 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976459, encodeId=a83c9e645937, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67634708538, createdName=1356548325, createdTime=Thu Jun 24 09:35:13 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976431, encodeId=66529e643116, content=消耗1积分!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Thu Jun 24 08:12:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976414, encodeId=7e3e9e6414e1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Thu Jun 24 06:51:30 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976405, encodeId=ff069e64055b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faae5295647, createdName=148728e5m16暂无昵称, createdTime=Thu Jun 24 06:13:25 CST 2021, time=2021-06-24, status=1, ipAttribution=)]
    2021-06-24 weigq

    消耗1积分!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1665584, encodeId=ec1316655842d, content=<a href='/topic/show?id=66134464223' target=_blank style='color:#2F92EE;'>#女性性功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44642, encryptionId=66134464223, topicName=女性性功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e825973246, createdName=12498ef1m39(暂无昵称), createdTime=Wed Jan 19 00:02:05 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977135, encodeId=fcfd9e7135ab, content=Mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac645513469, createdName=ms6000000413596970, createdTime=Sat Jun 26 21:17:47 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421375, encodeId=32dd14213e547, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Fri Jun 25 13:02:05 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611105, encodeId=6b7b1611105a4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jun 25 13:02:05 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976459, encodeId=a83c9e645937, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67634708538, createdName=1356548325, createdTime=Thu Jun 24 09:35:13 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976431, encodeId=66529e643116, content=消耗1积分!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Thu Jun 24 08:12:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976414, encodeId=7e3e9e6414e1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Thu Jun 24 06:51:30 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976405, encodeId=ff069e64055b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faae5295647, createdName=148728e5m16暂无昵称, createdTime=Thu Jun 24 06:13:25 CST 2021, time=2021-06-24, status=1, ipAttribution=)]
    2021-06-24 大郎该吃药了

    学习了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1665584, encodeId=ec1316655842d, content=<a href='/topic/show?id=66134464223' target=_blank style='color:#2F92EE;'>#女性性功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44642, encryptionId=66134464223, topicName=女性性功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e825973246, createdName=12498ef1m39(暂无昵称), createdTime=Wed Jan 19 00:02:05 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977135, encodeId=fcfd9e7135ab, content=Mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac645513469, createdName=ms6000000413596970, createdTime=Sat Jun 26 21:17:47 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421375, encodeId=32dd14213e547, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Fri Jun 25 13:02:05 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611105, encodeId=6b7b1611105a4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jun 25 13:02:05 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976459, encodeId=a83c9e645937, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67634708538, createdName=1356548325, createdTime=Thu Jun 24 09:35:13 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976431, encodeId=66529e643116, content=消耗1积分!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Thu Jun 24 08:12:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976414, encodeId=7e3e9e6414e1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Thu Jun 24 06:51:30 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976405, encodeId=ff069e64055b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faae5295647, createdName=148728e5m16暂无昵称, createdTime=Thu Jun 24 06:13:25 CST 2021, time=2021-06-24, status=1, ipAttribution=)]
    2021-06-24 148728e5m16暂无昵称

    学习了

    0

相关资讯

Sci Rep:女性中由大肠杆菌引起的泌尿系感染研究

许多女性含有泌尿系感染(UTIs)。除了疼痛和尿急之外,恶臭也是这些患者的显著特征。引起上述特征的特定因子仍旧不清楚。目前为止,也没有有效靶向治疗。

Sci Rep:携带RET融合基因的女性肺癌患者独特的遗传特征和临床预后

携带RET融合基因的女性肺癌患者具有独特的遗传特征,并且预后不良。

NEURON:女性更易抑郁的生物学基础被发现

抑郁症是一种常见的疾病,已有的研究显示,女性的发病率是男性的两倍。

PeerJ:颈动脉内-中膜厚度与突发感音神经性耳聋相关性研究

心血管因素与突发感音神经性耳聋(SSNHL)的病理生理特性和风险存在相关性。然而,关于颈动脉内-中膜厚度(IMT)与SSNHL风险和各自的治疗结果之间的关系仍旧了解很少。

BMJ Nutrition Prevention & Health:针对中国人群体的研究,相比于男性,女性更应控制碳水摄入

高血压作为一种常见的慢性病,是诱发心脑血管疾病最主要的危险因素,时刻威胁着人们的生命健康。在我国,高血压的患病率从1959年的5.1%上升至2014年的29.6%,增长势头强劲。

IBD: 女性溃疡性结肠炎患者初始手术类型对生育的影响

溃疡性结肠炎(UC)是一种肠道慢性免疫疾病,仅在美国就影响了近100万人,预计这一数字在未来十年内还会上升。大多数患有UC的患者需要终身服药来治疗